Salamatu Abdul-Aziz
Dr Nawaraj Bhattarai
Professor Luke Vale
Dr Gurdeep Sagoo
Dr Asima Mukhopadhyay
et al. | Challenges and opportunities to address the emerging burden of targeted therapies in ovarian cancer | 2025 |
|
Cyril Onwuelazu Uteh
Eugenie Johnson
Tomos Robinson
Dr Najmeh Moradi
Alex Inskip
et al. | Uncertainty in Matching-Adjusted Indirect Comparisons Using Real-World Evidence: Evidence Assessment Group Perspective | 2025 |
|
Dr Gurdeep Sagoo
| Determining the impact of an artificial intelligence tool on the management of pulmonary nodules detected incidentally on CT (DOLCE) study protocol: a prospective, non-interventional multicentre UK study | 2024 |
|
Dr Najmeh Moradi
Nicole O'Connor
Dr Katie Thomson
Dr Hosein Shabaninejad
Tumi Sotire
et al. | NICE Approaches to Expert Opinion Evidence in Highly Specialised Technologies: Time to Change? Evidence Assessment Group Perspective | 2024 |
|
Dr Gurdeep Sagoo
| Normalising the Implementation of Pharmacogenomic (PGx) Testing in Adult Mental Health Settings: A Theory-Based Systematic Review | 2024 |
|
Dr Gurdeep Sagoo
| Proportion of Antipsychotics with CYP2D6 Pharmacogenetic (PGx) Associations Prescribed in an Early Intervention in Psychosis (EIP) Cohort: A Cross-Sectional Study | 2024 |
|
Dr Gurdeep Sagoo
| Cost-effectiveness of decellularised bone allograft compared with fresh-frozen bone allograft for acetabular impaction bone grafting during a revision hip arthroplasty in the UK | 2023 |
|
Dr Gurdeep Sagoo
| Cost-effectiveness requirements for implementing artificial intelligence technology in the Women’s UK Breast Cancer Screening service | 2023 |
|
Dr Gurdeep Sagoo
Tomos Robinson
Dr Diarmuid Coughlan
Dr Nick Meader
Stephen Rice
et al. | Evaluating high-cost technologies–no need to throw the baby out with the bathwater | 2023 |
|
Dr Katie Thomson
Nicole O'Connor
Dr Hosein Shabaninejad
Tumi Sotire
Madeleine Still
et al. | Highly Specialised Technology appraisal - Sebelipase alfa for treating Wolman disease (rapidly progressive LAL-D) [ID3995] | 2023 |
|
Dr Gurdeep Sagoo
| Learning from parental experience in a neonatal surgical unit: a qualitative service evaluation | 2023 |
|
Dr Gurdeep Sagoo
| Developing a method to capture parental experience in a neonatal surgical centre in the context of COVID-19: A qualitative study | 2022 |
|
Dr Gurdeep Sagoo
| Early economic evaluation of an intervention to improve uptake of the NHS England Diabetes Prevention Programme | 2022 |
|
Dr Gurdeep Sagoo
| The cost-effectiveness of using rapid diagnostic tests for the diagnosis of typhoid fever in patients with suspected typhoid fever: a systematic review | 2022 |
|
Dr Gurdeep Sagoo
| We must start using pharmacogenomic information to optimise medicines for older people | 2022 |
|
Dr Gurdeep Sagoo
| An Analysis of Pharmacogenomic-Guided Pathways and Their Effect on Medication Changes and Hospital Admissions: A Systematic Review and Meta-Analysis | 2021 |
|
Dr Gurdeep Sagoo
| Cost analysis of managing B3 breast lesions by vacuum excision at Leeds Breast Unit using a decision model | 2021 |
|
Dr Gurdeep Sagoo
| Cost-effectiveness analysis of telephone-based cognitive behaviour therapy compared to treatment as usual CBT for cancer patients: Evidence from a small, randomised controlled trial | 2021 |
|
Dr Helen Marshall
Professor Ruth Plummer
Dr Gurdeep Sagoo
| The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma | 2021 |
|
Dr Gurdeep Sagoo
| What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings? | 2021 |
|
Dr Gurdeep Sagoo
Dr Joy Allen
Dr Sara Graziadio
Eoin Moloney
| Early Economic Evaluation of Diagnostic Technologies: Experiences of the NIHR Diagnostic Evidence Co-operatives | 2019 |
|
Dr Gurdeep Sagoo
| 'Personalized medicine': What's in a name? | 2014 |
|
